CervoMed Stock (NASDAQ: CRVO) stock price, news, charts, stock research, profile.
Open | $15.46 |
Close | - |
Volume / Avg. | 21.09K / 48.91K |
Day Range | 15.27 - 16.00 |
52 Wk Range | 4.28 - 26.38 |
Market Cap | $127.60M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 30 |
Short Interest | 3.4% |
Days to Cover | 4.38 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of CervoMed (NASDAQ:CRVO) through any online brokerage.
Other companies in CervoMed’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Galectin Therapeutics (NASDAQ:GALT), Tevogen Bio Holdings (NASDAQ:TVGN), aTyr Pharma (NASDAQ:ATYR) and Adagene (NASDAQ:ADAG).
There is no analysis for CervoMed.
CervoMed has a consensus price target of $66.00.
The stock price for CervoMed (NASDAQ: CRVO) is $15.46 last updated Today at July 9, 2024 at 9:27 AM EDT.
There are no upcoming dividends for CervoMed.
CervoMed’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for CervoMed.
CervoMed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.